http://www.novabay.com
NovaBay Pharmaceuticals, Inc. Company Intro
NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company developing products for the eye care market.
Industry
Healthcare
NovaBay Pharmaceuticals, Inc. Headquaters
2000 Powell Street
EmeryVille,94608
United States
NovaBay Pharmaceuticals, Inc. Share price
26 Oct 2020 02:08 GMT
$0.7400
0.01 (1.37 %)
NovaBay Pharmaceuticals, Inc. Market cap
$30.257 M
WMC RANKING
2020
NovaBay Pharmaceuticals, Inc. # 156
BiotechnologyLatest NovaBay Pharmaceuticals, Inc. News
25 Oct 2020
(2020-2026) Viral Conjunctivitis Pipeline Drugs Market Segmentation, Analysis by Recent Trends, Development & Growth by Regions | RAdenovir Pharma AB, Allergan Plc, NanoViricides
... Development & Growth by Regions | RAdenovir Pharma AB, Allergan Plc, ... Inc, Shire Plc, NovaBay Pharmaceuticals, Inc, Novartis AG, Panoptes Pharma ...
25 Oct 2020
Impetigo Treatment Market (2020-2026) | Where Should Participant Focus To Gain Maximum ROI | Exclusive Report By DataIntelo
NovaBay Pharmaceuticals, Inc. Pfizer, Inc. Ranbaxy Laboratories Limited Roche Holding AG SANDOZ GmbH. Taro Pharmaceutical Industries Ltd Teva ...
25 Oct 2020
(2020-2026) Viral Conjunctivitis Pipeline Drugs Market Segmentation, Analysis by Recent Trends, Development & Growth by Regions | RAdenovir Pharma AB, Allergan Plc, NanoViricides
... Development & Growth by Regions | RAdenovir Pharma AB, Allergan Plc, ... Inc, Shire Plc, NovaBay Pharmaceuticals, Inc, Novartis AG, Panoptes Pharma ...
WMC Market Score
WMC Market to Revenue Score
| Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score | |
| NovaBay Pharmaceuticals, Inc. | 0.12 | 9.33 | 1.68 | 0 | 0 | 0 | 8.37 |
| Alexion Pharmaceuticals, Inc. | 100 | 13.26 | 100 | 18 | 0 | 0 | 100 |
| Vertex Pharmaceuticals Incorporated | 97.58 | 100 | 4.09 | 25 | 0 | 0 | 98.33 |
| 3SBio Inc. | 96.05 | 0 | 0 | 4 | 0 | 0 | 2.80 |
| Incyte Corporation | 40.27 | 14.26 | 7.21 | 100 | 0 | 0 | 92.34 |
NovaBay Pharmaceuticals, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| NovaBay Pharmaceuticals, Inc. | $6,599 | $14,261 | $-10,487 | $30.257M | 156 |
| Alexion Pharmaceuticals, Inc. | $5,536,800 | $2,523,000 | $846,100 | $26.654B | 1 |
| Vertex Pharmaceuticals Incorporated | $5,402,685 | $2,634,428 | $2,080,775 | $55.11B | 2 |
| 3SBio Inc. | ¥5,318,091 | ¥3,085,221 | ¥973,717 | ¥19.42B | 3 |
| Incyte Corporation | $2,229,409 | $1,622,822 | $446,906 | $19.615B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total NovaBay Pharmaceuticals, Inc. Social Followers vs Top 4 Industry Competitors
NovaBay Pharmaceuticals, Inc. Post vs Top 4 Industry Competitors
Book a demo
A free one-on-one demo with one of our team and see exactly what the WMC business intelligence platform can do for your organisation.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
